Pages 3 - 12 Volume 80, Issue 1
Decompressive surgery for treating nerve damage in leprosy. A Cochrane review

Decompressive surgery is used for treating nerve damage in leprosy. We assessed the effectiveness of decompressive surgery for patients with nerve damage due to leprosy.


A broad search strategy was performed to find eligible studies, selecting randomised controlled trials (RCTs) comparing decompressive surgery alone or plus corticosteroids with corticosteroids alone, placebo or no treatment. Two authors independently assessed quality and extracted data. Where it was not possible to perform a meta-analysis, the data for each trial was summarised.


We included two randomised controlled trials involving 88 people. The trials examined the added benefit of surgery over prednisolone for treatment of nerve damage of less than 6 months duration. After 2 years follow-up there was no significant difference in nerve function improvement between people treated with surgery plus prednisolone or with prednisolone alone. Adverse effects of decompression surgery were not adequately described.


Evidence from randomised controlled trials does not show a significant added benefit of surgery over steroid treatment alone. Well-designed randomised controlled trials are needed to establish the effectiveness of the combination of surgery and medical treatment compared to medical treatment alone.

Cite this article
Natasja H.J. Van Veen, Ton A.R. Schreuders, Willem J. Theuvenet, Amit Agrawal, Jan Hendrik Richardus;
Decompressive surgery for treating nerve damage in leprosy. A Cochrane review; Leprosy Review; 2009; 80; 1; 3-12; DOI: 10.47276/lr.80.1.3
Leprosy Review
British Leprosy Relief Association
Colchester, UK